Marek Lommatzsch

11PUBLICATIONS
22CO-AUTHORS
Disease surveillanceGene and molecular therapyMolecular targetsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 29, 2025
Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2.

Erika Penz, Thomas Rothe, Lieven Dupont

|May 30, 2025
Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction.

Renaud Louis, Marek Lommatzsch, David J Jackson

|Dec 26, 2023
Tezepelumab in patients with allergic and eosinophilic asthma.

Marco Caminati, Roland Buhl, Jonathan Corren

|Jan 05, 2022
IgE is associated with exacerbations and lung function decline in COPD.

Marek Lommatzsch, Timotheus Speer, Christian Herr

Pageof 2